The Biomarker Discovery Program is a multidisciplinary team that includes oncologists, surgeons, pathologists, molecular biologists, bioengineers, bioinformaticians and others. By combining expertise, the program takes a clinical question, and answers it through a four-phase approach: Discovery, experimental validation, preclinical validation and clinical validation.
The Co-Directors answer the following three questions in this video:
Discover the latest in Biomarkers, and Genomics, at our annual Individualizing Medicine Conferencethis year, October 6-8!
Tags: biomarker, Biomarker Discovery Program, biomarkers, Bladder Cancer, breast cancer, center for individualized medicine, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics, HER2, individualized medicine, John Cheville, Modern Pathology, personal genomics, personalized medicine, predictive medicine, Uncategorized